nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—SLC22A3—prostate cancer	0.251	0.582	CbGaD
Guanidine—SLC22A1—prostate cancer	0.18	0.418	CbGaD
Guanidine—SLC22A3—Estradiol—prostate cancer	0.0417	0.313	CbGbCtD
Guanidine—SLC22A2—Estradiol—prostate cancer	0.0247	0.185	CbGbCtD
Guanidine—SLC22A8—Conjugated Estrogens—prostate cancer	0.0241	0.181	CbGbCtD
Guanidine—SLC22A1—Estradiol—prostate cancer	0.0214	0.161	CbGbCtD
Guanidine—SLC22A8—Estradiol—prostate cancer	0.0212	0.159	CbGbCtD
Guanidine—KCNC2—prostate gland—prostate cancer	0.00332	0.0294	CbGeAlD
Guanidine—KCNG1—prostate gland—prostate cancer	0.00296	0.0262	CbGeAlD
Guanidine—GAMT—Podofilox—Etoposide—prostate cancer	0.00262	1	CbGdCrCtD
Guanidine—DLG4—prostate gland—prostate cancer	0.00258	0.0228	CbGeAlD
Guanidine—KCNV1—renal system—prostate cancer	0.0025	0.0221	CbGeAlD
Guanidine—KCNC4—prostate gland—prostate cancer	0.00246	0.0218	CbGeAlD
Guanidine—KCNQ4—prostate gland—prostate cancer	0.00237	0.0209	CbGeAlD
Guanidine—KCNQ5—prostate gland—prostate cancer	0.0023	0.0204	CbGeAlD
Guanidine—KCNG2—testis—prostate cancer	0.00227	0.0201	CbGeAlD
Guanidine—DLG4—seminal vesicle—prostate cancer	0.00218	0.0193	CbGeAlD
Guanidine—KCNS1—seminal vesicle—prostate cancer	0.00218	0.0193	CbGeAlD
Guanidine—KCNB1—epithelium—prostate cancer	0.00211	0.0186	CbGeAlD
Guanidine—KCNC3—epithelium—prostate cancer	0.00205	0.0181	CbGeAlD
Guanidine—KCNS1—epithelium—prostate cancer	0.00189	0.0167	CbGeAlD
Guanidine—KCNA5—prostate gland—prostate cancer	0.00189	0.0167	CbGeAlD
Guanidine—KCNS3—prostate gland—prostate cancer	0.00185	0.0163	CbGeAlD
Guanidine—SLC22A8—urine—prostate cancer	0.00181	0.016	CbGeAlD
Guanidine—RNASE1—prostate gland—prostate cancer	0.00179	0.0159	CbGeAlD
Guanidine—KCNF1—seminal vesicle—prostate cancer	0.00179	0.0158	CbGeAlD
Guanidine—DLG4—renal system—prostate cancer	0.00176	0.0155	CbGeAlD
Guanidine—GAMT—prostate gland—prostate cancer	0.00175	0.0154	CbGeAlD
Guanidine—KCNH6—prostate gland—prostate cancer	0.00169	0.0149	CbGeAlD
Guanidine—KCNS3—seminal vesicle—prostate cancer	0.00156	0.0138	CbGeAlD
Guanidine—KCNV2—testis—prostate cancer	0.00153	0.0136	CbGeAlD
Guanidine—RNASE1—seminal vesicle—prostate cancer	0.00152	0.0134	CbGeAlD
Guanidine—GAMT—seminal vesicle—prostate cancer	0.00148	0.0131	CbGeAlD
Guanidine—KCNH1—testis—prostate cancer	0.00146	0.0129	CbGeAlD
Guanidine—KCND3—prostate gland—prostate cancer	0.0014	0.0124	CbGeAlD
Guanidine—KCNQ1—prostate gland—prostate cancer	0.00136	0.012	CbGeAlD
Guanidine—KCNS3—epithelium—prostate cancer	0.00136	0.012	CbGeAlD
Guanidine—KCNG1—testis—prostate cancer	0.0013	0.0115	CbGeAlD
Guanidine—KCNH3—testis—prostate cancer	0.0013	0.0115	CbGeAlD
Guanidine—KCNA5—renal system—prostate cancer	0.00129	0.0114	CbGeAlD
Guanidine—KCNH8—testis—prostate cancer	0.00126	0.0112	CbGeAlD
Guanidine—KCNS3—renal system—prostate cancer	0.00126	0.0111	CbGeAlD
Guanidine—KCNS3—urethra—prostate cancer	0.00124	0.0109	CbGeAlD
Guanidine—KCNC3—testis—prostate cancer	0.00123	0.0108	CbGeAlD
Guanidine—RNASE1—urethra—prostate cancer	0.0012	0.0106	CbGeAlD
Guanidine—GAMT—renal system—prostate cancer	0.00119	0.0105	CbGeAlD
Guanidine—GAMT—urethra—prostate cancer	0.00117	0.0103	CbGeAlD
Guanidine—KCNQ1—seminal vesicle—prostate cancer	0.00115	0.0102	CbGeAlD
Guanidine—KCNH6—renal system—prostate cancer	0.00115	0.0102	CbGeAlD
Guanidine—DLG4—testis—prostate cancer	0.00114	0.01	CbGeAlD
Guanidine—KCNS1—testis—prostate cancer	0.00114	0.01	CbGeAlD
Guanidine—KCNA2—testis—prostate cancer	0.00114	0.01	CbGeAlD
Guanidine—KCNC4—testis—prostate cancer	0.00109	0.0096	CbGeAlD
Guanidine—KCND1—testis—prostate cancer	0.00109	0.0096	CbGeAlD
Guanidine—KCNH7—testis—prostate cancer	0.00104	0.00922	CbGeAlD
Guanidine—KCNC1—testis—prostate cancer	0.00104	0.00922	CbGeAlD
Guanidine—KCNQ4—testis—prostate cancer	0.00104	0.00922	CbGeAlD
Guanidine—ALDH2—prostate gland—prostate cancer	0.000948	0.00838	CbGeAlD
Guanidine—KCNQ1—renal system—prostate cancer	0.000927	0.0082	CbGeAlD
Guanidine—RNASE1—bone marrow—prostate cancer	0.000925	0.00818	CbGeAlD
Guanidine—KCNQ1—urethra—prostate cancer	0.000911	0.00805	CbGeAlD
Guanidine—KCNA3—lymph node—prostate cancer	0.000865	0.00765	CbGeAlD
Guanidine—KCNA5—testis—prostate cancer	0.000832	0.00735	CbGeAlD
Guanidine—KCNA2—lymph node—prostate cancer	0.000823	0.00728	CbGeAlD
Guanidine—DLG4—lymph node—prostate cancer	0.000823	0.00728	CbGeAlD
Guanidine—KCNS3—testis—prostate cancer	0.000814	0.0072	CbGeAlD
Guanidine—ALDH2—seminal vesicle—prostate cancer	0.000802	0.00709	CbGeAlD
Guanidine—RNASE1—testis—prostate cancer	0.000791	0.00699	CbGeAlD
Guanidine—KCNC4—lymph node—prostate cancer	0.000787	0.00696	CbGeAlD
Guanidine—GAMT—testis—prostate cancer	0.000769	0.0068	CbGeAlD
Guanidine—KCNQ2—testis—prostate cancer	0.000749	0.00663	CbGeAlD
Guanidine—SLC22A4—prostate gland—prostate cancer	0.000741	0.00655	CbGeAlD
Guanidine—KCNQ5—lymph node—prostate cancer	0.000736	0.0065	CbGeAlD
Guanidine—KCND2—testis—prostate cancer	0.00071	0.00628	CbGeAlD
Guanidine—KCNQ1—bone marrow—prostate cancer	0.000701	0.0062	CbGeAlD
Guanidine—SLC22A2—renal system—prostate cancer	0.00068	0.00602	CbGeAlD
Guanidine—SLC22A3—prostate gland—prostate cancer	0.000674	0.00596	CbGeAlD
Guanidine—SLC22A8—prostate gland—prostate cancer	0.000648	0.00573	CbGeAlD
Guanidine—ALDH2—renal system—prostate cancer	0.000646	0.00571	CbGeAlD
Guanidine—ALDH2—urethra—prostate cancer	0.000635	0.00561	CbGeAlD
Guanidine—SLC22A4—seminal vesicle—prostate cancer	0.000626	0.00554	CbGeAlD
Guanidine—KCND3—testis—prostate cancer	0.000619	0.00547	CbGeAlD
Guanidine—KCNA5—lymph node—prostate cancer	0.000603	0.00533	CbGeAlD
Guanidine—KCNQ1—testis—prostate cancer	0.000599	0.0053	CbGeAlD
Guanidine—KCNS3—lymph node—prostate cancer	0.00059	0.00522	CbGeAlD
Guanidine—RNASE1—lymph node—prostate cancer	0.000573	0.00507	CbGeAlD
Guanidine—SLC22A3—seminal vesicle—prostate cancer	0.00057	0.00504	CbGeAlD
Guanidine—GAMT—lymph node—prostate cancer	0.000557	0.00493	CbGeAlD
Guanidine—KCNH2—prostate gland—prostate cancer	0.000518	0.00458	CbGeAlD
Guanidine—SLC22A4—renal system—prostate cancer	0.000505	0.00446	CbGeAlD
Guanidine—SLC22A5—prostate gland—prostate cancer	0.00049	0.00433	CbGeAlD
Guanidine—ALDH2—bone marrow—prostate cancer	0.000489	0.00432	CbGeAlD
Guanidine—SLC22A1—renal system—prostate cancer	0.000481	0.00425	CbGeAlD
Guanidine—SLC22A3—renal system—prostate cancer	0.000459	0.00406	CbGeAlD
Guanidine—SLC22A3—urethra—prostate cancer	0.000451	0.00399	CbGeAlD
Guanidine—KCND3—lymph node—prostate cancer	0.000449	0.00397	CbGeAlD
Guanidine—SLC22A8—renal system—prostate cancer	0.000442	0.00391	CbGeAlD
Guanidine—KCNH2—seminal vesicle—prostate cancer	0.000439	0.00388	CbGeAlD
Guanidine—KCNQ1—lymph node—prostate cancer	0.000434	0.00384	CbGeAlD
Guanidine—ALDH2—testis—prostate cancer	0.000418	0.00369	CbGeAlD
Guanidine—SLC22A5—seminal vesicle—prostate cancer	0.000414	0.00366	CbGeAlD
Guanidine—SLC22A4—bone marrow—prostate cancer	0.000382	0.00337	CbGeAlD
Guanidine—KCNH2—renal system—prostate cancer	0.000353	0.00312	CbGeAlD
Guanidine—KCNH2—urethra—prostate cancer	0.000347	0.00307	CbGeAlD
Guanidine—SLC22A5—renal system—prostate cancer	0.000334	0.00295	CbGeAlD
Guanidine—SLC22A5—urethra—prostate cancer	0.000328	0.0029	CbGeAlD
Guanidine—Diarrhoea—Cabazitaxel—prostate cancer	0.00031	0.00226	CcSEcCtD
Guanidine—Abdominal pain—Bicalutamide—prostate cancer	0.000308	0.00224	CcSEcCtD
Guanidine—Body temperature increased—Bicalutamide—prostate cancer	0.000308	0.00224	CcSEcCtD
Guanidine—Anaemia—Goserelin—prostate cancer	0.000307	0.00223	CcSEcCtD
Guanidine—Vascular purpura—Capecitabine—prostate cancer	0.000304	0.00222	CcSEcCtD
Guanidine—Rash—Degarelix—prostate cancer	0.000304	0.00221	CcSEcCtD
Guanidine—Dermatitis—Degarelix—prostate cancer	0.000303	0.00221	CcSEcCtD
Guanidine—ALDH2—lymph node—prostate cancer	0.000303	0.00268	CbGeAlD
Guanidine—Ecchymosis—Prednisone—prostate cancer	0.000302	0.0022	CcSEcCtD
Guanidine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000301	0.00219	CcSEcCtD
Guanidine—Sweating—Mitoxantrone—prostate cancer	0.0003	0.00219	CcSEcCtD
Guanidine—Dizziness—Cabazitaxel—prostate cancer	0.0003	0.00219	CcSEcCtD
Guanidine—SLC22A3—testis—prostate cancer	0.000297	0.00263	CbGeAlD
Guanidine—Leukopenia—Goserelin—prostate cancer	0.000297	0.00216	CcSEcCtD
Guanidine—Atrial fibrillation—Docetaxel—prostate cancer	0.000297	0.00216	CcSEcCtD
Guanidine—Petechiae—Doxorubicin—prostate cancer	0.000294	0.00214	CcSEcCtD
Guanidine—Palpitations—Goserelin—prostate cancer	0.000293	0.00214	CcSEcCtD
Guanidine—Palpitations—Conjugated Estrogens—prostate cancer	0.00029	0.00212	CcSEcCtD
Guanidine—Atrial fibrillation—Capecitabine—prostate cancer	0.000287	0.00209	CcSEcCtD
Guanidine—Nausea—Degarelix—prostate cancer	0.000286	0.00208	CcSEcCtD
Guanidine—Purpura—Capecitabine—prostate cancer	0.000282	0.00206	CcSEcCtD
Guanidine—Flushing—Estradiol—prostate cancer	0.00028	0.00204	CcSEcCtD
Guanidine—Dry mouth—Goserelin—prostate cancer	0.000276	0.00201	CcSEcCtD
Guanidine—Confusional state—Goserelin—prostate cancer	0.000273	0.00199	CcSEcCtD
Guanidine—Vascular purpura—Prednisone—prostate cancer	0.000271	0.00198	CcSEcCtD
Guanidine—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000271	0.00198	CcSEcCtD
Guanidine—Nausea—Cabazitaxel—prostate cancer	0.000269	0.00196	CcSEcCtD
Guanidine—KCNH2—bone marrow—prostate cancer	0.000267	0.00236	CbGeAlD
Guanidine—Diarrhoea—Bicalutamide—prostate cancer	0.000266	0.00194	CcSEcCtD
Guanidine—Thrombocytopenia—Goserelin—prostate cancer	0.000265	0.00193	CcSEcCtD
Guanidine—Ataxia—Docetaxel—prostate cancer	0.000264	0.00193	CcSEcCtD
Guanidine—Tachycardia—Goserelin—prostate cancer	0.000264	0.00193	CcSEcCtD
Guanidine—Hyperhidrosis—Goserelin—prostate cancer	0.000262	0.00191	CcSEcCtD
Guanidine—Tachycardia—Conjugated Estrogens—prostate cancer	0.000262	0.00191	CcSEcCtD
Guanidine—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.00026	0.0019	CcSEcCtD
Guanidine—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00026	0.0019	CcSEcCtD
Guanidine—Irritability—Capecitabine—prostate cancer	0.00026	0.00189	CcSEcCtD
Guanidine—Liver function test abnormal—Docetaxel—prostate cancer	0.00026	0.00189	CcSEcCtD
Guanidine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000259	0.00189	CcSEcCtD
Guanidine—Anorexia—Goserelin—prostate cancer	0.000258	0.00188	CcSEcCtD
Guanidine—Tension—Estradiol—prostate cancer	0.000258	0.00188	CcSEcCtD
Guanidine—Mood swings—Capecitabine—prostate cancer	0.000258	0.00188	CcSEcCtD
Guanidine—Dizziness—Bicalutamide—prostate cancer	0.000257	0.00188	CcSEcCtD
Guanidine—Ataxia—Capecitabine—prostate cancer	0.000256	0.00187	CcSEcCtD
Guanidine—Anorexia—Conjugated Estrogens—prostate cancer	0.000256	0.00186	CcSEcCtD
Guanidine—Nervousness—Estradiol—prostate cancer	0.000255	0.00186	CcSEcCtD
Guanidine—Hypotension—Goserelin—prostate cancer	0.000253	0.00184	CcSEcCtD
Guanidine—Purpura—Prednisone—prostate cancer	0.000252	0.00183	CcSEcCtD
Guanidine—Liver function test abnormal—Capecitabine—prostate cancer	0.000251	0.00183	CcSEcCtD
Guanidine—Hypotension—Conjugated Estrogens—prostate cancer	0.00025	0.00183	CcSEcCtD
Guanidine—Tremor—Estradiol—prostate cancer	0.000246	0.0018	CcSEcCtD
Guanidine—Rash—Bicalutamide—prostate cancer	0.000245	0.00179	CcSEcCtD
Guanidine—Dermatitis—Bicalutamide—prostate cancer	0.000245	0.00179	CcSEcCtD
Guanidine—Paraesthesia—Goserelin—prostate cancer	0.000243	0.00177	CcSEcCtD
Guanidine—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000241	0.00176	CcSEcCtD
Guanidine—Affect lability—Prednisone—prostate cancer	0.000239	0.00174	CcSEcCtD
Guanidine—Psychotic disorder—Prednisone—prostate cancer	0.000237	0.00173	CcSEcCtD
Guanidine—SLC22A4—lymph node—prostate cancer	0.000236	0.00209	CbGeAlD
Guanidine—Ecchymosis—Epirubicin—prostate cancer	0.000236	0.00172	CcSEcCtD
Guanidine—Decreased appetite—Goserelin—prostate cancer	0.000235	0.00172	CcSEcCtD
Guanidine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000233	0.0017	CcSEcCtD
Guanidine—Palpitations—Estradiol—prostate cancer	0.000232	0.00169	CcSEcCtD
Guanidine—Irritability—Prednisone—prostate cancer	0.000231	0.00169	CcSEcCtD
Guanidine—Nausea—Bicalutamide—prostate cancer	0.000231	0.00168	CcSEcCtD
Guanidine—Mood swings—Prednisone—prostate cancer	0.00023	0.00167	CcSEcCtD
Guanidine—KCNH2—testis—prostate cancer	0.000228	0.00202	CbGeAlD
Guanidine—Anaemia—Mitoxantrone—prostate cancer	0.000226	0.00165	CcSEcCtD
Guanidine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000225	0.00164	CcSEcCtD
Guanidine—Feeling abnormal—Goserelin—prostate cancer	0.000223	0.00163	CcSEcCtD
Guanidine—Leukopenia—Mitoxantrone—prostate cancer	0.000219	0.0016	CcSEcCtD
Guanidine—Dry mouth—Estradiol—prostate cancer	0.000219	0.0016	CcSEcCtD
Guanidine—Ecchymosis—Doxorubicin—prostate cancer	0.000219	0.00159	CcSEcCtD
Guanidine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000217	0.00159	CcSEcCtD
Guanidine—Flushing—Etoposide—prostate cancer	0.000217	0.00158	CcSEcCtD
Guanidine—Confusional state—Estradiol—prostate cancer	0.000216	0.00158	CcSEcCtD
Guanidine—SLC22A5—testis—prostate cancer	0.000216	0.00191	CbGeAlD
Guanidine—SLC22A3—lymph node—prostate cancer	0.000215	0.0019	CbGeAlD
Guanidine—Abdominal pain—Goserelin—prostate cancer	0.000214	0.00156	CcSEcCtD
Guanidine—Body temperature increased—Goserelin—prostate cancer	0.000214	0.00156	CcSEcCtD
Guanidine—Vascular purpura—Epirubicin—prostate cancer	0.000212	0.00155	CcSEcCtD
Guanidine—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000212	0.00155	CcSEcCtD
Guanidine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000212	0.00155	CcSEcCtD
Guanidine—Tachycardia—Estradiol—prostate cancer	0.000209	0.00153	CcSEcCtD
Guanidine—Hyperhidrosis—Estradiol—prostate cancer	0.000207	0.00151	CcSEcCtD
Guanidine—Rash—Ethinyl Estradiol—prostate cancer	0.000207	0.00151	CcSEcCtD
Guanidine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000207	0.00151	CcSEcCtD
Guanidine—Confusional state—Mitoxantrone—prostate cancer	0.000202	0.00147	CcSEcCtD
Guanidine—Purpura—Epirubicin—prostate cancer	0.000197	0.00143	CcSEcCtD
Guanidine—Vascular purpura—Doxorubicin—prostate cancer	0.000196	0.00143	CcSEcCtD
Guanidine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000196	0.00143	CcSEcCtD
Guanidine—Nausea—Ethinyl Estradiol—prostate cancer	0.000195	0.00142	CcSEcCtD
Guanidine—Tachycardia—Mitoxantrone—prostate cancer	0.000195	0.00142	CcSEcCtD
Guanidine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000193	0.00141	CcSEcCtD
Guanidine—Paraesthesia—Estradiol—prostate cancer	0.000193	0.0014	CcSEcCtD
Guanidine—Anorexia—Mitoxantrone—prostate cancer	0.000191	0.00139	CcSEcCtD
Guanidine—Anaemia—Etoposide—prostate cancer	0.000188	0.00137	CcSEcCtD
Guanidine—Hypotension—Mitoxantrone—prostate cancer	0.000187	0.00136	CcSEcCtD
Guanidine—Affect lability—Epirubicin—prostate cancer	0.000187	0.00136	CcSEcCtD
Guanidine—Decreased appetite—Estradiol—prostate cancer	0.000187	0.00136	CcSEcCtD
Guanidine—Diarrhoea—Goserelin—prostate cancer	0.000185	0.00135	CcSEcCtD
Guanidine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000183	0.00134	CcSEcCtD
Guanidine—Leukopenia—Etoposide—prostate cancer	0.000182	0.00133	CcSEcCtD
Guanidine—Purpura—Doxorubicin—prostate cancer	0.000182	0.00133	CcSEcCtD
Guanidine—Flushing—Docetaxel—prostate cancer	0.000181	0.00132	CcSEcCtD
Guanidine—Mood swings—Epirubicin—prostate cancer	0.00018	0.00131	CcSEcCtD
Guanidine—Paraesthesia—Mitoxantrone—prostate cancer	0.00018	0.00131	CcSEcCtD
Guanidine—Dizziness—Goserelin—prostate cancer	0.000179	0.0013	CcSEcCtD
Guanidine—Ataxia—Epirubicin—prostate cancer	0.000178	0.0013	CcSEcCtD
Guanidine—Dizziness—Conjugated Estrogens—prostate cancer	0.000177	0.00129	CcSEcCtD
Guanidine—Feeling abnormal—Estradiol—prostate cancer	0.000177	0.00129	CcSEcCtD
Guanidine—Liver function test abnormal—Epirubicin—prostate cancer	0.000175	0.00128	CcSEcCtD
Guanidine—Flushing—Capecitabine—prostate cancer	0.000175	0.00127	CcSEcCtD
Guanidine—Decreased appetite—Mitoxantrone—prostate cancer	0.000174	0.00127	CcSEcCtD
Guanidine—Affect lability—Doxorubicin—prostate cancer	0.000173	0.00126	CcSEcCtD
Guanidine—Rash—Goserelin—prostate cancer	0.000171	0.00124	CcSEcCtD
Guanidine—Dermatitis—Goserelin—prostate cancer	0.00017	0.00124	CcSEcCtD
Guanidine—Body temperature increased—Estradiol—prostate cancer	0.00017	0.00124	CcSEcCtD
Guanidine—Abdominal pain—Estradiol—prostate cancer	0.00017	0.00124	CcSEcCtD
Guanidine—Rash—Conjugated Estrogens—prostate cancer	0.000169	0.00123	CcSEcCtD
Guanidine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000169	0.00123	CcSEcCtD
Guanidine—Confusional state—Etoposide—prostate cancer	0.000168	0.00122	CcSEcCtD
Guanidine—Hallucination—Prednisone—prostate cancer	0.000167	0.00122	CcSEcCtD
Guanidine—Mood swings—Doxorubicin—prostate cancer	0.000166	0.00121	CcSEcCtD
Guanidine—KCNH2—lymph node—prostate cancer	0.000166	0.00146	CbGeAlD
Guanidine—Ataxia—Doxorubicin—prostate cancer	0.000165	0.0012	CcSEcCtD
Guanidine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000165	0.0012	CcSEcCtD
Guanidine—Thrombocytopenia—Etoposide—prostate cancer	0.000163	0.00119	CcSEcCtD
Guanidine—Tachycardia—Etoposide—prostate cancer	0.000162	0.00118	CcSEcCtD
Guanidine—Liver function test abnormal—Doxorubicin—prostate cancer	0.000162	0.00118	CcSEcCtD
Guanidine—Nausea—Goserelin—prostate cancer	0.000161	0.00117	CcSEcCtD
Guanidine—Hyperhidrosis—Etoposide—prostate cancer	0.000161	0.00117	CcSEcCtD
Guanidine—Nausea—Conjugated Estrogens—prostate cancer	0.000159	0.00116	CcSEcCtD
Guanidine—Anorexia—Etoposide—prostate cancer	0.000159	0.00116	CcSEcCtD
Guanidine—Body temperature increased—Mitoxantrone—prostate cancer	0.000158	0.00115	CcSEcCtD
Guanidine—Abdominal pain—Mitoxantrone—prostate cancer	0.000158	0.00115	CcSEcCtD
Guanidine—Anaemia—Docetaxel—prostate cancer	0.000157	0.00114	CcSEcCtD
Guanidine—SLC22A5—lymph node—prostate cancer	0.000156	0.00138	CbGeAlD
Guanidine—Flushing—Prednisone—prostate cancer	0.000156	0.00114	CcSEcCtD
Guanidine—Hypotension—Etoposide—prostate cancer	0.000155	0.00113	CcSEcCtD
Guanidine—Tremor—Capecitabine—prostate cancer	0.000154	0.00112	CcSEcCtD
Guanidine—Leukopenia—Docetaxel—prostate cancer	0.000152	0.00111	CcSEcCtD
Guanidine—Anaemia—Capecitabine—prostate cancer	0.000152	0.0011	CcSEcCtD
Guanidine—Palpitations—Docetaxel—prostate cancer	0.00015	0.00109	CcSEcCtD
Guanidine—Paraesthesia—Etoposide—prostate cancer	0.000149	0.00109	CcSEcCtD
Guanidine—Diarrhoea—Estradiol—prostate cancer	0.000147	0.00107	CcSEcCtD
Guanidine—Leukopenia—Capecitabine—prostate cancer	0.000147	0.00107	CcSEcCtD
Guanidine—Palpitations—Capecitabine—prostate cancer	0.000145	0.00106	CcSEcCtD
Guanidine—Decreased appetite—Etoposide—prostate cancer	0.000145	0.00105	CcSEcCtD
Guanidine—Dizziness—Estradiol—prostate cancer	0.000142	0.00103	CcSEcCtD
Guanidine—Dry mouth—Docetaxel—prostate cancer	0.000141	0.00103	CcSEcCtD
Guanidine—Sweating—Epirubicin—prostate cancer	0.00014	0.00102	CcSEcCtD
Guanidine—Confusional state—Docetaxel—prostate cancer	0.000139	0.00102	CcSEcCtD
Guanidine—Feeling abnormal—Etoposide—prostate cancer	0.000137	0.000999	CcSEcCtD
Guanidine—Diarrhoea—Mitoxantrone—prostate cancer	0.000137	0.000997	CcSEcCtD
Guanidine—Dry mouth—Capecitabine—prostate cancer	0.000137	0.000995	CcSEcCtD
Guanidine—Thrombocytopenia—Docetaxel—prostate cancer	0.000135	0.000986	CcSEcCtD
Guanidine—Rash—Estradiol—prostate cancer	0.000135	0.000986	CcSEcCtD
Guanidine—Dermatitis—Estradiol—prostate cancer	0.000135	0.000985	CcSEcCtD
Guanidine—Anaemia—Prednisone—prostate cancer	0.000135	0.000984	CcSEcCtD
Guanidine—Confusional state—Capecitabine—prostate cancer	0.000135	0.000984	CcSEcCtD
Guanidine—Tachycardia—Docetaxel—prostate cancer	0.000135	0.000983	CcSEcCtD
Guanidine—Anorexia—Docetaxel—prostate cancer	0.000132	0.00096	CcSEcCtD
Guanidine—Abdominal pain—Etoposide—prostate cancer	0.000131	0.000958	CcSEcCtD
Guanidine—Body temperature increased—Etoposide—prostate cancer	0.000131	0.000958	CcSEcCtD
Guanidine—Thrombocytopenia—Capecitabine—prostate cancer	0.000131	0.000955	CcSEcCtD
Guanidine—Tachycardia—Capecitabine—prostate cancer	0.000131	0.000952	CcSEcCtD
Guanidine—Sweating—Doxorubicin—prostate cancer	0.00013	0.000945	CcSEcCtD
Guanidine—Hyperhidrosis—Capecitabine—prostate cancer	0.000129	0.000943	CcSEcCtD
Guanidine—Hypotension—Docetaxel—prostate cancer	0.000129	0.000941	CcSEcCtD
Guanidine—Anorexia—Capecitabine—prostate cancer	0.000128	0.00093	CcSEcCtD
Guanidine—Nausea—Estradiol—prostate cancer	0.000127	0.000929	CcSEcCtD
Guanidine—Rash—Mitoxantrone—prostate cancer	0.000126	0.000919	CcSEcCtD
Guanidine—Dermatitis—Mitoxantrone—prostate cancer	0.000126	0.000918	CcSEcCtD
Guanidine—Hypotension—Capecitabine—prostate cancer	0.000125	0.000912	CcSEcCtD
Guanidine—Paraesthesia—Docetaxel—prostate cancer	0.000124	0.000905	CcSEcCtD
Guanidine—Flushing—Epirubicin—prostate cancer	0.000122	0.000888	CcSEcCtD
Guanidine—Paraesthesia—Capecitabine—prostate cancer	0.00012	0.000876	CcSEcCtD
Guanidine—Decreased appetite—Docetaxel—prostate cancer	0.00012	0.000876	CcSEcCtD
Guanidine—Nausea—Mitoxantrone—prostate cancer	0.000119	0.000866	CcSEcCtD
Guanidine—Tachycardia—Prednisone—prostate cancer	0.000116	0.000848	CcSEcCtD
Guanidine—Decreased appetite—Capecitabine—prostate cancer	0.000116	0.000848	CcSEcCtD
Guanidine—Hyperhidrosis—Prednisone—prostate cancer	0.000115	0.00084	CcSEcCtD
Guanidine—Feeling abnormal—Docetaxel—prostate cancer	0.000114	0.00083	CcSEcCtD
Guanidine—Diarrhoea—Etoposide—prostate cancer	0.000114	0.00083	CcSEcCtD
Guanidine—Anorexia—Prednisone—prostate cancer	0.000114	0.000828	CcSEcCtD
Guanidine—Flushing—Doxorubicin—prostate cancer	0.000113	0.000821	CcSEcCtD
Guanidine—Tension—Epirubicin—prostate cancer	0.000112	0.000817	CcSEcCtD
Guanidine—Nervousness—Epirubicin—prostate cancer	0.000111	0.000809	CcSEcCtD
Guanidine—Feeling abnormal—Capecitabine—prostate cancer	0.00011	0.000804	CcSEcCtD
Guanidine—Dizziness—Etoposide—prostate cancer	0.00011	0.000802	CcSEcCtD
Guanidine—Body temperature increased—Docetaxel—prostate cancer	0.000109	0.000796	CcSEcCtD
Guanidine—Abdominal pain—Docetaxel—prostate cancer	0.000109	0.000796	CcSEcCtD
Guanidine—Paraesthesia—Prednisone—prostate cancer	0.000107	0.00078	CcSEcCtD
Guanidine—Body temperature increased—Capecitabine—prostate cancer	0.000106	0.000771	CcSEcCtD
Guanidine—Abdominal pain—Capecitabine—prostate cancer	0.000106	0.000771	CcSEcCtD
Guanidine—Anaemia—Epirubicin—prostate cancer	0.000106	0.00077	CcSEcCtD
Guanidine—Rash—Etoposide—prostate cancer	0.000105	0.000764	CcSEcCtD
Guanidine—Dermatitis—Etoposide—prostate cancer	0.000105	0.000764	CcSEcCtD
Guanidine—Tension—Doxorubicin—prostate cancer	0.000104	0.000756	CcSEcCtD
Guanidine—Decreased appetite—Prednisone—prostate cancer	0.000104	0.000755	CcSEcCtD
Guanidine—Nervousness—Doxorubicin—prostate cancer	0.000103	0.000748	CcSEcCtD
Guanidine—Leukopenia—Epirubicin—prostate cancer	0.000102	0.000745	CcSEcCtD
Guanidine—Palpitations—Epirubicin—prostate cancer	0.000101	0.000736	CcSEcCtD
Guanidine—Nausea—Etoposide—prostate cancer	9.88e-05	0.00072	CcSEcCtD
Guanidine—Feeling abnormal—Prednisone—prostate cancer	9.82e-05	0.000716	CcSEcCtD
Guanidine—Anaemia—Doxorubicin—prostate cancer	9.77e-05	0.000712	CcSEcCtD
Guanidine—Dry mouth—Epirubicin—prostate cancer	9.51e-05	0.000693	CcSEcCtD
Guanidine—Leukopenia—Doxorubicin—prostate cancer	9.46e-05	0.00069	CcSEcCtD
Guanidine—Diarrhoea—Docetaxel—prostate cancer	9.46e-05	0.000689	CcSEcCtD
Guanidine—Abdominal pain—Prednisone—prostate cancer	9.42e-05	0.000687	CcSEcCtD
Guanidine—Body temperature increased—Prednisone—prostate cancer	9.42e-05	0.000687	CcSEcCtD
Guanidine—Confusional state—Epirubicin—prostate cancer	9.4e-05	0.000685	CcSEcCtD
Guanidine—Palpitations—Doxorubicin—prostate cancer	9.34e-05	0.000681	CcSEcCtD
Guanidine—Diarrhoea—Capecitabine—prostate cancer	9.15e-05	0.000667	CcSEcCtD
Guanidine—Dizziness—Docetaxel—prostate cancer	9.14e-05	0.000666	CcSEcCtD
Guanidine—Thrombocytopenia—Epirubicin—prostate cancer	9.13e-05	0.000665	CcSEcCtD
Guanidine—Tachycardia—Epirubicin—prostate cancer	9.1e-05	0.000663	CcSEcCtD
Guanidine—Hyperhidrosis—Epirubicin—prostate cancer	9.01e-05	0.000657	CcSEcCtD
Guanidine—Anorexia—Epirubicin—prostate cancer	8.89e-05	0.000648	CcSEcCtD
Guanidine—Dizziness—Capecitabine—prostate cancer	8.85e-05	0.000645	CcSEcCtD
Guanidine—Dry mouth—Doxorubicin—prostate cancer	8.8e-05	0.000642	CcSEcCtD
Guanidine—Rash—Docetaxel—prostate cancer	8.71e-05	0.000635	CcSEcCtD
Guanidine—Hypotension—Epirubicin—prostate cancer	8.71e-05	0.000635	CcSEcCtD
Guanidine—Dermatitis—Docetaxel—prostate cancer	8.71e-05	0.000635	CcSEcCtD
Guanidine—Confusional state—Doxorubicin—prostate cancer	8.7e-05	0.000634	CcSEcCtD
Guanidine—Thrombocytopenia—Doxorubicin—prostate cancer	8.44e-05	0.000616	CcSEcCtD
Guanidine—Rash—Capecitabine—prostate cancer	8.44e-05	0.000615	CcSEcCtD
Guanidine—Dermatitis—Capecitabine—prostate cancer	8.43e-05	0.000614	CcSEcCtD
Guanidine—Tachycardia—Doxorubicin—prostate cancer	8.42e-05	0.000614	CcSEcCtD
Guanidine—Paraesthesia—Epirubicin—prostate cancer	8.37e-05	0.00061	CcSEcCtD
Guanidine—Hyperhidrosis—Doxorubicin—prostate cancer	8.34e-05	0.000608	CcSEcCtD
Guanidine—Anorexia—Doxorubicin—prostate cancer	8.22e-05	0.000599	CcSEcCtD
Guanidine—Nausea—Docetaxel—prostate cancer	8.21e-05	0.000598	CcSEcCtD
Guanidine—Diarrhoea—Prednisone—prostate cancer	8.15e-05	0.000595	CcSEcCtD
Guanidine—Decreased appetite—Epirubicin—prostate cancer	8.1e-05	0.000591	CcSEcCtD
Guanidine—Hypotension—Doxorubicin—prostate cancer	8.06e-05	0.000588	CcSEcCtD
Guanidine—Nausea—Capecitabine—prostate cancer	7.95e-05	0.000579	CcSEcCtD
Guanidine—Dizziness—Prednisone—prostate cancer	7.88e-05	0.000575	CcSEcCtD
Guanidine—Paraesthesia—Doxorubicin—prostate cancer	7.74e-05	0.000565	CcSEcCtD
Guanidine—Feeling abnormal—Epirubicin—prostate cancer	7.68e-05	0.00056	CcSEcCtD
Guanidine—Rash—Prednisone—prostate cancer	7.51e-05	0.000548	CcSEcCtD
Guanidine—Dermatitis—Prednisone—prostate cancer	7.51e-05	0.000547	CcSEcCtD
Guanidine—Decreased appetite—Doxorubicin—prostate cancer	7.5e-05	0.000547	CcSEcCtD
Guanidine—Abdominal pain—Epirubicin—prostate cancer	7.37e-05	0.000537	CcSEcCtD
Guanidine—Body temperature increased—Epirubicin—prostate cancer	7.37e-05	0.000537	CcSEcCtD
Guanidine—Feeling abnormal—Doxorubicin—prostate cancer	7.11e-05	0.000518	CcSEcCtD
Guanidine—Nausea—Prednisone—prostate cancer	7.08e-05	0.000516	CcSEcCtD
Guanidine—Abdominal pain—Doxorubicin—prostate cancer	6.82e-05	0.000497	CcSEcCtD
Guanidine—Body temperature increased—Doxorubicin—prostate cancer	6.82e-05	0.000497	CcSEcCtD
Guanidine—Diarrhoea—Epirubicin—prostate cancer	6.38e-05	0.000465	CcSEcCtD
Guanidine—Dizziness—Epirubicin—prostate cancer	6.16e-05	0.000449	CcSEcCtD
Guanidine—Diarrhoea—Doxorubicin—prostate cancer	5.9e-05	0.00043	CcSEcCtD
Guanidine—Rash—Epirubicin—prostate cancer	5.88e-05	0.000428	CcSEcCtD
Guanidine—Dermatitis—Epirubicin—prostate cancer	5.87e-05	0.000428	CcSEcCtD
Guanidine—Dizziness—Doxorubicin—prostate cancer	5.7e-05	0.000416	CcSEcCtD
Guanidine—Nausea—Epirubicin—prostate cancer	5.54e-05	0.000404	CcSEcCtD
Guanidine—Rash—Doxorubicin—prostate cancer	5.44e-05	0.000396	CcSEcCtD
Guanidine—Dermatitis—Doxorubicin—prostate cancer	5.43e-05	0.000396	CcSEcCtD
Guanidine—Nausea—Doxorubicin—prostate cancer	5.12e-05	0.000374	CcSEcCtD
Guanidine—SLC22A2—Metabolism—SULT1E1—prostate cancer	7.26e-06	3.98e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SRD5A1—prostate cancer	7.26e-06	3.98e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—GSTM1—prostate cancer	7.23e-06	3.96e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TNFRSF21—prostate cancer	7.14e-06	3.91e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—LPL—prostate cancer	7.1e-06	3.89e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOA3—prostate cancer	7.01e-06	3.84e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CB—prostate cancer	6.98e-06	3.82e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.97e-06	3.82e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP7B1—prostate cancer	6.94e-06	3.8e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—EP300—prostate cancer	6.94e-06	3.8e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MTAP—prostate cancer	6.94e-06	3.8e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ACSL4—prostate cancer	6.93e-06	3.79e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HSD17B3—prostate cancer	6.93e-06	3.79e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PTGS2—prostate cancer	6.92e-06	3.79e-05	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	6.9e-06	3.78e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CYP1A1—prostate cancer	6.86e-06	3.76e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ERCC2—prostate cancer	6.8e-06	3.72e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SULT1E1—prostate cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SRD5A1—prostate cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—HPGDS—prostate cancer	6.69e-06	3.66e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP2C19—prostate cancer	6.65e-06	3.64e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—UMPS—prostate cancer	6.64e-06	3.64e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PHGDH—prostate cancer	6.64e-06	3.64e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ARG2—prostate cancer	6.64e-06	3.64e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.61e-06	3.62e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—LDHB—prostate cancer	6.51e-06	3.57e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTT1—prostate cancer	6.49e-06	3.55e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ACHE—prostate cancer	6.49e-06	3.55e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HSD17B3—prostate cancer	6.46e-06	3.54e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ACSL4—prostate cancer	6.46e-06	3.54e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—IL6—prostate cancer	6.44e-06	3.53e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—IL6—prostate cancer	6.44e-06	3.53e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP2A6—prostate cancer	6.41e-06	3.51e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—MTHFR—prostate cancer	6.39e-06	3.5e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP3A5—prostate cancer	6.39e-06	3.5e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PTEN—prostate cancer	6.36e-06	3.49e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PTEN—prostate cancer	6.36e-06	3.49e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PTEN—prostate cancer	6.36e-06	3.49e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—RXRA—prostate cancer	6.28e-06	3.44e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PPARA—prostate cancer	6.27e-06	3.43e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—AKR1C3—prostate cancer	6.24e-06	3.42e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PRKACB—prostate cancer	6.21e-06	3.4e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ARG2—prostate cancer	6.19e-06	3.39e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PHGDH—prostate cancer	6.19e-06	3.39e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—UMPS—prostate cancer	6.19e-06	3.39e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PDHA1—prostate cancer	6.17e-06	3.38e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—UCP3—prostate cancer	6.17e-06	3.38e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTA3—prostate cancer	6.17e-06	3.38e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TCN2—prostate cancer	6.17e-06	3.38e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.16e-06	3.37e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP17A1—prostate cancer	6.14e-06	3.36e-05	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.08e-06	3.33e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—EP300—prostate cancer	6.07e-06	3.32e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—EP300—prostate cancer	6.07e-06	3.32e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—EP300—prostate cancer	6.07e-06	3.32e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—LDHB—prostate cancer	6.07e-06	3.32e-05	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.06e-06	3.32e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PTEN—prostate cancer	6.03e-06	3.3e-05	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—MDM2—prostate cancer	6.02e-06	3.3e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP3A5—prostate cancer	5.96e-06	3.26e-05	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—AKT1—prostate cancer	5.94e-06	3.25e-05	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—AKT1—prostate cancer	5.94e-06	3.25e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CAV1—prostate cancer	5.9e-06	3.23e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HSD3B1—prostate cancer	5.89e-06	3.23e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC22A3—prostate cancer	5.89e-06	3.23e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	5.86e-06	3.21e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOA2—prostate cancer	5.85e-06	3.21e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PDHA1—prostate cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—EP300—prostate cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—UCP3—prostate cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTA3—prostate cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TCN2—prostate cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTA4—prostate cancer	5.65e-06	3.09e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TBXAS1—prostate cancer	5.65e-06	3.09e-05	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—MDM2—prostate cancer	5.61e-06	3.07e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—SLC5A5—prostate cancer	5.58e-06	3.06e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTA2—prostate cancer	5.5e-06	3.01e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HSD3B1—prostate cancer	5.49e-06	3.01e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SLC22A3—prostate cancer	5.49e-06	3.01e-05	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.48e-06	3e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP2E1—prostate cancer	5.45e-06	2.99e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SULT1A1—prostate cancer	5.44e-06	2.98e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ABCG5—prostate cancer	5.44e-06	2.98e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NQO1—prostate cancer	5.39e-06	2.95e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CG—prostate cancer	5.37e-06	2.94e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—TH—prostate cancer	5.32e-06	2.91e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTA1—prostate cancer	5.31e-06	2.91e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TBXAS1—prostate cancer	5.26e-06	2.88e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTA4—prostate cancer	5.26e-06	2.88e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP3A4—prostate cancer	5.26e-06	2.88e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HSD3B2—prostate cancer	5.25e-06	2.87e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NAT2—prostate cancer	5.25e-06	2.87e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTO1—prostate cancer	5.25e-06	2.87e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP1B1—prostate cancer	5.17e-06	2.83e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PIK3CA—prostate cancer	5.14e-06	2.81e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTA2—prostate cancer	5.13e-06	2.81e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—INS—prostate cancer	5.08e-06	2.78e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ABCG5—prostate cancer	5.07e-06	2.77e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SULT1A1—prostate cancer	5.07e-06	2.77e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP2C18—prostate cancer	5.03e-06	2.76e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—LRP2—prostate cancer	5.03e-06	2.76e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PLCB2—prostate cancer	5.03e-06	2.76e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GGT1—prostate cancer	5.01e-06	2.74e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CREBBP—prostate cancer	4.98e-06	2.73e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTA1—prostate cancer	4.95e-06	2.71e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—P4HB—prostate cancer	4.94e-06	2.7e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NCOA1—prostate cancer	4.93e-06	2.7e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HSD3B2—prostate cancer	4.89e-06	2.68e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTO1—prostate cancer	4.89e-06	2.68e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NAT2—prostate cancer	4.89e-06	2.68e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP19A1—prostate cancer	4.86e-06	2.66e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC22A1—prostate cancer	4.8e-06	2.63e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.8e-06	2.63e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CD—prostate cancer	4.72e-06	2.59e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—RXRA—prostate cancer	4.69e-06	2.57e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP2C18—prostate cancer	4.69e-06	2.57e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PLCB2—prostate cancer	4.69e-06	2.57e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—LRP2—prostate cancer	4.69e-06	2.57e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SULT2A1—prostate cancer	4.68e-06	2.56e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—MED12—prostate cancer	4.6e-06	2.52e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—P4HB—prostate cancer	4.6e-06	2.52e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GNG5—prostate cancer	4.57e-06	2.5e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—COMT—prostate cancer	4.52e-06	2.48e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTP1—prostate cancer	4.5e-06	2.46e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PIK3CA—prostate cancer	4.49e-06	2.46e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PIK3CA—prostate cancer	4.49e-06	2.46e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PIK3CA—prostate cancer	4.49e-06	2.46e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.47e-06	2.45e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—NOS3—prostate cancer	4.46e-06	2.44e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ITPR1—prostate cancer	4.43e-06	2.42e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOA3—prostate cancer	4.4e-06	2.41e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SULT2A1—prostate cancer	4.36e-06	2.39e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MED12—prostate cancer	4.29e-06	2.35e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PIK3CA—prostate cancer	4.26e-06	2.33e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GNG5—prostate cancer	4.26e-06	2.33e-05	CbGpPWpGaD
Guanidine—GAMT—Metabolism—AKT1—prostate cancer	4.2e-06	2.3e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—HPGDS—prostate cancer	4.2e-06	2.3e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—TYMS—prostate cancer	4.18e-06	2.29e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP2C19—prostate cancer	4.17e-06	2.28e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—GSTM1—prostate cancer	4.13e-06	2.26e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CB—prostate cancer	4.12e-06	2.25e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOA3—prostate cancer	4.1e-06	2.25e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTGS2—prostate cancer	4.08e-06	2.23e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ACHE—prostate cancer	4.07e-06	2.23e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTT1—prostate cancer	4.07e-06	2.23e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—LPL—prostate cancer	4.06e-06	2.22e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP2A6—prostate cancer	4.02e-06	2.2e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CYP1A1—prostate cancer	3.92e-06	2.15e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—AKR1C3—prostate cancer	3.91e-06	2.14e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—HPGDS—prostate cancer	3.91e-06	2.14e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PRKACB—prostate cancer	3.89e-06	2.13e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP2C19—prostate cancer	3.89e-06	2.13e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ERCC2—prostate cancer	3.89e-06	2.13e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP17A1—prostate cancer	3.85e-06	2.11e-05	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.81e-06	2.09e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTT1—prostate cancer	3.79e-06	2.08e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ACHE—prostate cancer	3.79e-06	2.08e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP2A6—prostate cancer	3.75e-06	2.05e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOA2—prostate cancer	3.67e-06	2.01e-05	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—AKT1—prostate cancer	3.67e-06	2.01e-05	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—AKT1—prostate cancer	3.67e-06	2.01e-05	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—AKT1—prostate cancer	3.67e-06	2.01e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—MTHFR—prostate cancer	3.65e-06	2e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—AKR1C3—prostate cancer	3.65e-06	2e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PRKACB—prostate cancer	3.63e-06	1.99e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP17A1—prostate cancer	3.59e-06	1.97e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PPARA—prostate cancer	3.58e-06	1.96e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTEN—prostate cancer	3.56e-06	1.95e-05	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.55e-06	1.95e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—SLC5A5—prostate cancer	3.5e-06	1.92e-05	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—AKT1—prostate cancer	3.48e-06	1.9e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOA2—prostate cancer	3.42e-06	1.87e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP2E1—prostate cancer	3.42e-06	1.87e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—EP300—prostate cancer	3.39e-06	1.86e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NQO1—prostate cancer	3.38e-06	1.85e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CAV1—prostate cancer	3.37e-06	1.85e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TH—prostate cancer	3.33e-06	1.83e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP3A4—prostate cancer	3.3e-06	1.81e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—SLC5A5—prostate cancer	3.26e-06	1.79e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP1B1—prostate cancer	3.24e-06	1.78e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP2E1—prostate cancer	3.19e-06	1.75e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NQO1—prostate cancer	3.15e-06	1.73e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GGT1—prostate cancer	3.14e-06	1.72e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TH—prostate cancer	3.11e-06	1.7e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NCOA1—prostate cancer	3.09e-06	1.69e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP3A4—prostate cancer	3.07e-06	1.68e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CG—prostate cancer	3.07e-06	1.68e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP19A1—prostate cancer	3.05e-06	1.67e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP1B1—prostate cancer	3.02e-06	1.66e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—RXRA—prostate cancer	2.94e-06	1.61e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GGT1—prostate cancer	2.93e-06	1.6e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—INS—prostate cancer	2.91e-06	1.59e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NCOA1—prostate cancer	2.88e-06	1.58e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CREBBP—prostate cancer	2.85e-06	1.56e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP19A1—prostate cancer	2.84e-06	1.56e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—COMT—prostate cancer	2.83e-06	1.55e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTP1—prostate cancer	2.82e-06	1.55e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ITPR1—prostate cancer	2.78e-06	1.52e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—RXRA—prostate cancer	2.74e-06	1.5e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CD—prostate cancer	2.7e-06	1.48e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—COMT—prostate cancer	2.64e-06	1.45e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTP1—prostate cancer	2.63e-06	1.44e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—TYMS—prostate cancer	2.62e-06	1.44e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—GSTM1—prostate cancer	2.59e-06	1.42e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ITPR1—prostate cancer	2.59e-06	1.42e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—NOS3—prostate cancer	2.55e-06	1.4e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—LPL—prostate cancer	2.54e-06	1.39e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PIK3CA—prostate cancer	2.51e-06	1.37e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CYP1A1—prostate cancer	2.46e-06	1.35e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—TYMS—prostate cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ERCC2—prostate cancer	2.44e-06	1.34e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—GSTM1—prostate cancer	2.42e-06	1.32e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—LPL—prostate cancer	2.37e-06	1.3e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CB—prostate cancer	2.35e-06	1.29e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTGS2—prostate cancer	2.33e-06	1.28e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—MTHFR—prostate cancer	2.29e-06	1.25e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CYP1A1—prostate cancer	2.29e-06	1.25e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ERCC2—prostate cancer	2.27e-06	1.24e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PPARA—prostate cancer	2.25e-06	1.23e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—MTHFR—prostate cancer	2.14e-06	1.17e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CAV1—prostate cancer	2.11e-06	1.16e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PPARA—prostate cancer	2.1e-06	1.15e-05	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—AKT1—prostate cancer	2.05e-06	1.12e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTEN—prostate cancer	2.03e-06	1.11e-05	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CAV1—prostate cancer	1.97e-06	1.08e-05	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—EP300—prostate cancer	1.94e-06	1.06e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CG—prostate cancer	1.93e-06	1.05e-05	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—INS—prostate cancer	1.82e-06	9.98e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CG—prostate cancer	1.79e-06	9.83e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CREBBP—prostate cancer	1.78e-06	9.78e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—INS—prostate cancer	1.7e-06	9.3e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CD—prostate cancer	1.69e-06	9.27e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CREBBP—prostate cancer	1.66e-06	9.11e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—NOS3—prostate cancer	1.6e-06	8.75e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CD—prostate cancer	1.58e-06	8.64e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—NOS3—prostate cancer	1.49e-06	8.16e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CB—prostate cancer	1.48e-06	8.08e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTGS2—prostate cancer	1.46e-06	8.01e-06	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PIK3CA—prostate cancer	1.43e-06	7.85e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.37e-06	7.53e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTGS2—prostate cancer	1.36e-06	7.46e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTEN—prostate cancer	1.27e-06	6.98e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—EP300—prostate cancer	1.22e-06	6.66e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTEN—prostate cancer	1.19e-06	6.51e-06	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—AKT1—prostate cancer	1.17e-06	6.41e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—EP300—prostate cancer	1.13e-06	6.21e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PIK3CA—prostate cancer	8.99e-07	4.93e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PIK3CA—prostate cancer	8.38e-07	4.59e-06	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—AKT1—prostate cancer	7.35e-07	4.02e-06	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—AKT1—prostate cancer	6.85e-07	3.75e-06	CbGpPWpGaD
